Apolipoprotein C3 (ApoC3) secretion is elevated in patients with type II diabetes [78] and its overexpression results in decreased adipose lipolysis and increased fatty acid uptake by adipose depots [79]. Here, APOC3 is linked to type 2 diabetes mellitus.